drugset / Trial / NCT05312294
Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years
RandomizedParallel-groupDouble-blindPrevention
Summary
Comparative assessment of the tolerability, safety, and immunogenicity of the Flu-M® Inactivated Split Influenza Vaccine (without preservative) and the Flu-M® vaccine (with preservative) in volunteers aged between 18 and 60
Timeline
- Start
- 2020-12-07
- Primary completion
- 2021-09-03
- Completion
- 2021-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flu-M | Vaccine | 0.5 ml | Intramuscular |
| Subject | Flu-M | Vaccine | 0.5 ml | Intramuscular |